• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通气治疗的患儿接受肺表面活性物质补充后的表面活性物质磷脂动力学。

Surfactant Phospholipid Kinetics in Ventilated Children after Therapeutic Surfactant Supplementation.

机构信息

NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton SO16 6YD, UK.

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.

出版信息

Int J Mol Sci. 2024 Sep 29;25(19):10480. doi: 10.3390/ijms251910480.

DOI:10.3390/ijms251910480
PMID:39408809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11477192/
Abstract

Acute lung Injury leads to alterations in surfactant lipid composition and metabolism. Although several mechanisms contribute to dysregulated surfactant metabolism, studies investigating in vivo surfactant metabolism are limited. The aim of this study is to characterise surfactant phospholipid composition and flux utilising a stable isotope labelling technique in mechanically ventilated paediatric patients. Paediatric patients (<16 years of age) received 3.6 mg/kg intravenous -D-choline chloride followed by the endotracheal instillation of 100 mg/kg of exogenous surfactant after 24 h. Bronchioalveolar fluid samples were taken at baseline and 12, 24, 36, 48, 72 and 96 h after -D-choline infusion. Nine participants (median age of 48 days) were recruited. The primary phosphatidylcholine (PC) composition consisted of PC16:0/16:0 or DPPC (32.0 ± 4.5%). Surfactant supplementation resulted in a 30% increase in DPPC. -D PC enrichment was detected after 12 h and differed significantly between patients, suggesting variability in surfactant synthesis/secretion by the CDP-choline pathway. Peak enrichment was achieved (0.94 ± 0.15% of total PC) at 24 h after -D-choline infusion. There was a trend towards reduced enrichment with the duration of mechanical ventilation prior to study recruitment; however, this was not statistically significant ( = 0.19). In this study, we demonstrated the fractional molecular composition and turnover of surfactant phospholipids, which was highly variable between patients.

摘要

急性肺损伤导致表面活性剂脂质组成和代谢发生改变。尽管有几种机制导致表面活性剂代谢失调,但研究表明,研究体内表面活性剂代谢的研究是有限的。本研究旨在利用稳定同位素标记技术,对机械通气的儿科患者的表面活性剂磷脂组成和通量进行特征描述。儿科患者(<16 岁)接受 3.6mg/kg 的静脉内-D-胆碱氯化物,24 小时后经气管内滴注 100mg/kg 的外源性表面活性剂。在-D-胆碱输注后 12、24、36、48、72 和 96 小时时采集支气管肺泡液样本。招募了 9 名参与者(中位年龄为 48 天)。主要的磷脂酰胆碱(PC)组成由 PC16:0/16:0 或 DPPC(32.0±4.5%)组成。表面活性剂补充导致 DPPC 增加 30%。在 12 小时后检测到-D-PC 富集,并且患者之间存在显著差异,这表明 CDP-胆碱途径的表面活性剂合成/分泌存在差异。在-D-胆碱输注后 24 小时达到峰值富集(总 PC 的 0.94±0.15%)。在研究招募之前,机械通气的持续时间与富集呈下降趋势;然而,这没有统计学意义(=0.19)。在这项研究中,我们展示了表面活性剂磷脂的分数分子组成和周转率,患者之间存在很大的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/788e813e2a61/ijms-25-10480-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/adab7fa8c329/ijms-25-10480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/524ccdd94fbd/ijms-25-10480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/930ad630532a/ijms-25-10480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/e51f1a6e2930/ijms-25-10480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/25a6cc19a457/ijms-25-10480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/788e813e2a61/ijms-25-10480-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/adab7fa8c329/ijms-25-10480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/524ccdd94fbd/ijms-25-10480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/930ad630532a/ijms-25-10480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/e51f1a6e2930/ijms-25-10480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/25a6cc19a457/ijms-25-10480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcfa/11477192/788e813e2a61/ijms-25-10480-g006.jpg

相似文献

1
Surfactant Phospholipid Kinetics in Ventilated Children after Therapeutic Surfactant Supplementation.通气治疗的患儿接受肺表面活性物质补充后的表面活性物质磷脂动力学。
Int J Mol Sci. 2024 Sep 29;25(19):10480. doi: 10.3390/ijms251910480.
2
Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers.健康志愿者不同支气管内部分的磷脂组成和动力学。
BMC Pulm Med. 2014 Feb 1;14:10. doi: 10.1186/1471-2466-14-10.
3
Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome.急性呼吸窘迫综合征患者表面活性物质磷脂酰胆碱合成的分子特异性改变。
Respir Res. 2014 Nov 7;15(1):128. doi: 10.1186/s12931-014-0128-8.
4
Phosphatidylcholine kinetics in neonatal rat lungs and the effects of rhuKGF and betamethasone.新生大鼠肺中磷脂酰胆碱动力学以及重组人角质形成细胞生长因子和倍他米松的作用
Am J Physiol Lung Cell Mol Physiol. 2016 May 15;310(10):L955-63. doi: 10.1152/ajplung.00010.2016. Epub 2016 Mar 4.
5
Insight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndrome.健康人群和急性呼吸窘迫综合征患者红细胞磷脂分子流的研究。
PLoS One. 2019 Aug 27;14(8):e0221595. doi: 10.1371/journal.pone.0221595. eCollection 2019.
6
Metabolism of surfactant phosphatidylcholine molecular species in cftr(tm1HGU/tm1HGU) mice compared to MF-1 mice.与MF-1小鼠相比,cftr(tm1HGU/tm1HGU)小鼠中表面活性物质磷脂酰胆碱分子种类的代谢
Exp Lung Res. 2001 Jun;27(4):349-66. doi: 10.1080/019021401750193610.
7
Analysis of lung surfactant phosphatidylcholine metabolism in transgenic mice using stable isotopes.利用稳定同位素分析转基因小鼠肺表面活性物质卵磷脂代谢。
Chem Phys Lipids. 2011 Sep;164(6):549-55. doi: 10.1016/j.chemphyslip.2011.04.004. Epub 2011 Apr 15.
8
Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.儿童急性肺损伤时的表面活性剂磷脂、表面活性剂蛋白和炎症标志物。
Pediatr Crit Care Med. 2010 Jan;11(1):82-91. doi: 10.1097/PCC.0b013e3181ae5a4c.
9
Surfactant phosphatidylcholine metabolism and surfactant function in preterm, ventilated lambs.早产、机械通气羔羊的表面活性物质磷脂酰胆碱代谢与表面活性物质功能
Am Rev Respir Dis. 1989 Feb;139(2):352-9. doi: 10.1164/ajrccm/139.2.352.
10
Endogenous surfactant metabolism in critically ill infants measured with stable isotope labeled fatty acids.用稳定同位素标记脂肪酸测量危重症婴儿的内源性表面活性物质代谢。
Pediatr Res. 1999 Feb;45(2):242-6. doi: 10.1203/00006450-199902000-00015.

本文引用的文献

1
Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions.成人急性呼吸窘迫综合征中的肺表面活性物质:当前观点与未来方向
Diagnostics (Basel). 2023 Sep 15;13(18):2964. doi: 10.3390/diagnostics13182964.
2
Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial.严重新型冠状病毒肺炎感染患者雾化吸入表面活性剂后的快速磷脂周转:一项随机临床试验
Am J Respir Crit Care Med. 2022 Feb 15;205(4):471-473. doi: 10.1164/rccm.202110-2279LE.
3
Constant Vt Ventilation and Surfactant Dysfunction: An Overlooked Cause of Ventilator-induced Lung Injury.
常频通气和表面活性物质功能障碍:呼吸机相关性肺损伤被忽视的原因。
Am J Respir Crit Care Med. 2022 Jan 15;205(2):152-160. doi: 10.1164/rccm.202107-1690CP.
4
Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.表面活性剂给药对急性呼吸窘迫综合征成年患者结局的影响:一项随机对照试验的荟萃分析。
BMC Pulm Med. 2019 Jan 9;19(1):9. doi: 10.1186/s12890-018-0761-y.
5
Phospholipid Remodeling in Physiology and Disease.磷脂代谢重编程在生理和疾病中的作用
Annu Rev Physiol. 2019 Feb 10;81:165-188. doi: 10.1146/annurev-physiol-020518-114444. Epub 2018 Oct 31.
6
Phospholipid methylation in mammals: from biochemistry to physiological function.哺乳动物中的磷脂甲基化:从生物化学到生理功能
Biochim Biophys Acta. 2014 Jun;1838(6):1477-87. doi: 10.1016/j.bbamem.2013.10.018. Epub 2013 Nov 1.
7
Pediatric calfactant in acute respiratory distress syndrome trial.儿科肺表面活性剂治疗急性呼吸窘迫综合征试验。
Pediatr Crit Care Med. 2013 Sep;14(7):657-65. doi: 10.1097/PCC.0b013e3182917b68.
8
Acute respiratory distress syndrome in children: physiology and management.儿童急性呼吸窘迫综合征:生理学与管理。
Curr Opin Pediatr. 2013 Jun;25(3):338-43. doi: 10.1097/MOP.0b013e328360bbe7.
9
Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?临床综述:外源性表面活性剂治疗急性肺损伤/急性呼吸窘迫综合征——我们从这里何去何从?
Crit Care. 2012 Nov 22;16(6):238. doi: 10.1186/cc11512.
10
Surfactant phospholipid metabolism.表面活性剂磷脂代谢
Biochim Biophys Acta. 2013 Mar;1831(3):612-25. doi: 10.1016/j.bbalip.2012.09.010. Epub 2012 Sep 29.